Evercore ISI has updated its outlook on CVS Health (NYSE:CVS) shares, raising the price target from $60.00 to $65.00 while ...

Looking ahead to fiscal year 2026, Evercore ISI projects an EPS growth of roughly 7% to $9.10. This forecast is based on a ...

Evercore ISI lowered the firm’s price target on Moderna (MRNA) to $50 from $60 and keeps an In Line rating on the shares. The firm is updating ...

We recently published a list of Top 10 AI News You Shouldn’t Miss. In this article, we are going to take a look at where ...

Discover the top U.S. Quant-rated industrial stocks with strong potential for growth and profitability in the current market ...

Evercore ISI added United Parcel Service ( NYSE: UPS) to its Tactical Outperform list ahead of the parcel delivery giant's ...

Evercore ISI raised the firm’s price target on Brinker (EAT) to $140 from $130 and keeps an In Line rating on the shares. Lower-income consumer trends and COVID-era pricing is weighing on ...

In a report released yesterday, John Pancari from Evercore ISI maintained a Hold rating on Comerica (CMA – Research Report), with a price ...

Evercore ISI analyst David Palmer lowered the firm’s price target on Wendy’s (WEN) to $18 from $19 and keeps an In Line rating on the shares. Lower-income consumer trends and COVID-era pricing ...

The Nasdaq 100 Index has nearly doubled since the start of 2023, adding $14 trillion in value in the process. Evercore ISI’s ...

Evercore ISI Director of Research Marc Harris said, “Artificial intelligence is already a transformative force in the U.S. economy, revolutionizing industries and driving innovation. Scaling ...